0001209191-18-039658.txt : 20180627 0001209191-18-039658.hdr.sgml : 20180627 20180627161759 ACCESSION NUMBER: 0001209191-18-039658 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180626 FILED AS OF DATE: 20180627 DATE AS OF CHANGE: 20180627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 18921972 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 675 W. KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-26 0 0001645460 Cue Biopharma, Inc. CUE 0001129890 DRISCOLL FREDERICK W 675 W. KENDALL STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (right to buy) 12.97 2018-06-26 4 A 0 50000 0.00 A 2025-06-26 Common Stock 50000 50000 D These Stock Options become exercisable in eight equal semi-annual installments beginning December 26, 2018. /s/ Frederick Driscoll by Mark Busch, as attorney-in-fact 2018-06-27